Global and United States Gastrointestinal OTC Drugs Market Insights, Forecast to 2026

Publisher Name :
Date: 27-Oct-2020
No. of pages: 145
Inquire Before Buying

Gastrointestinal OTC Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal OTC Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Gastrointestinal OTC Drugs market is segmented into

- Laxatives

- Anti-Flatulents

- H2-Antaginists

- Anti-Diarrheals

- PPIs

- Anti-Emetics

- Other

Segment by Application, the Gastrointestinal OTC Drugs market is segmented into

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Regional and Country-level Analysis

The Gastrointestinal OTC Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Gastrointestinal OTC Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Gastrointestinal OTC Drugs Market Share Analysis

Gastrointestinal OTC Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gastrointestinal OTC Drugs business, the date to enter into the Gastrointestinal OTC Drugs market, Gastrointestinal OTC Drugs product introduction, recent developments, etc.

The major vendors covered:

- GlaxoSmithKline

- Pfizer

- Johnson & Johnson

- Bayer

- Procter & Gamble

- Perrigo

- Abbott

- Sanofi

- Teva Pharmaceutical

- Nestle

- Boehringer Ingelheim

- Reckitt Benckiser

- Purdue Pharma

Global and United States Gastrointestinal OTC Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Gastrointestinal OTC Drugs Product Introduction
1.2 Market Segments
1.3 Key Gastrointestinal OTC Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type
1.4.2 Laxatives
1.4.3 Anti-Flatulents
1.4.4 H2-Antaginists
1.4.5 Anti-Diarrheals
1.4.6 PPIs
1.4.7 Anti-Emetics
1.4.8 Other
1.5 Market by Application
1.5.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal OTC Drugs Market Size, Estimates and Forecasts
2.1.1 Global Gastrointestinal OTC Drugs Revenue 2015-2026
2.1.2 Global Gastrointestinal OTC Drugs Sales 2015-2026
2.2 Global Gastrointestinal OTC Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Gastrointestinal OTC Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Gastrointestinal OTC Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Gastrointestinal OTC Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Gastrointestinal OTC Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Gastrointestinal OTC Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Region (2021-2026)
3 Global Gastrointestinal OTC Drugs Competitor Landscape by Players
3.1 Global Top Gastrointestinal OTC Drugs Sales by Manufacturers
3.1.1 Global Gastrointestinal OTC Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Gastrointestinal OTC Drugs Manufacturers by Revenue
3.2.1 Global Gastrointestinal OTC Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gastrointestinal OTC Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gastrointestinal OTC Drugs Revenue in 2019
3.2.5 Global Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Gastrointestinal OTC Drugs Price by Manufacturers
3.4 Global Gastrointestinal OTC Drugs Manufacturing Base Distribution, Product Types
3.4.1 Gastrointestinal OTC Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastrointestinal OTC Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Gastrointestinal OTC Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastrointestinal OTC Drugs Market Size by Type (2015-2020)
4.1.1 Global Gastrointestinal OTC Drugs Sales by Type (2015-2020)
4.1.2 Global Gastrointestinal OTC Drugs Revenue by Type (2015-2020)
4.1.3 Gastrointestinal OTC Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gastrointestinal OTC Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Gastrointestinal OTC Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Gastrointestinal OTC Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gastrointestinal OTC Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Gastrointestinal OTC Drugs Market Size by Application (2015-2020)
5.1.1 Global Gastrointestinal OTC Drugs Sales by Application (2015-2020)
5.1.2 Global Gastrointestinal OTC Drugs Revenue by Application (2015-2020)
5.1.3 Gastrointestinal OTC Drugs Price by Application (2015-2020)
5.2 Gastrointestinal OTC Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Gastrointestinal OTC Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Gastrointestinal OTC Drugs Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Gastrointestinal OTC Drugs Market Size YoY Growth 2015-2026
6.1.1 United States Gastrointestinal OTC Drugs Sales YoY Growth 2015-2026
6.1.2 United States Gastrointestinal OTC Drugs Revenue YoY Growth 2015-2026
6.1.3 United States Gastrointestinal OTC Drugs Market Share in Global Market 2015-2026
6.2 United States Gastrointestinal OTC Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Gastrointestinal OTC Drugs Players by Sales (2015-2020)
6.2.2 United States Top Gastrointestinal OTC Drugs Players by Revenue (2015-2020)
6.3 United States Gastrointestinal OTC Drugs Historic Market Review by Type (2015-2020)
6.3.1 United States Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020)
6.3.2 United States Gastrointestinal OTC Drugs Revenue Market Share by Type (2015-2020)
6.3.3 United States Gastrointestinal OTC Drugs Price by Type (2015-2020)
6.4 United States Gastrointestinal OTC Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Gastrointestinal OTC Drugs Sales Forecast by Type (2021-2026)
6.4.2 United States Gastrointestinal OTC Drugs Revenue Forecast by Type (2021-2026)
6.4.3 United States Gastrointestinal OTC Drugs Price Forecast by Type (2021-2026)
6.5 United States Gastrointestinal OTC Drugs Historic Market Review by Application (2015-2020)
6.5.1 United States Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
6.5.2 United States Gastrointestinal OTC Drugs Revenue Market Share by Application (2015-2020)
6.5.3 United States Gastrointestinal OTC Drugs Price by Application (2015-2020)
6.6 United States Gastrointestinal OTC Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Gastrointestinal OTC Drugs Sales Forecast by Application (2021-2026)
6.6.2 United States Gastrointestinal OTC Drugs Revenue Forecast by Application (2021-2026)
6.6.3 United States Gastrointestinal OTC Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Gastrointestinal OTC Drugs Market Size YoY Growth 2015-2026
7.2 North America Gastrointestinal OTC Drugs Market Facts & Figures by Country
7.2.1 North America Gastrointestinal OTC Drugs Sales by Country (2015-2020)
7.2.2 North America Gastrointestinal OTC Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Gastrointestinal OTC Drugs Market Size YoY Growth 2015-2026
8.2 Europe Gastrointestinal OTC Drugs Market Facts & Figures by Country
8.2.1 Europe Gastrointestinal OTC Drugs Sales by Country
8.2.2 Europe Gastrointestinal OTC Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Gastrointestinal OTC Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Gastrointestinal OTC Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Gastrointestinal OTC Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Gastrointestinal OTC Drugs Market Facts & Figures by Country
10.2.1 Latin America Gastrointestinal OTC Drugs Sales by Country
10.2.2 Latin America Gastrointestinal OTC Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Gastrointestinal OTC Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Gastrointestinal OTC Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Country
11.2.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Description and Business Overview
12.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Gastrointestinal OTC Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Description and Business Overview
12.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Bayer
12.4.1 Bayer Corporation Information
12.4.2 Bayer Description and Business Overview
12.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bayer Gastrointestinal OTC Drugs Products Offered
12.4.5 Bayer Recent Development
12.5 Procter & Gamble
12.5.1 Procter & Gamble Corporation Information
12.5.2 Procter & Gamble Description and Business Overview
12.5.3 Procter & Gamble Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Procter & Gamble Gastrointestinal OTC Drugs Products Offered
12.5.5 Procter & Gamble Recent Development
12.6 Perrigo
12.6.1 Perrigo Corporation Information
12.6.2 Perrigo Description and Business Overview
12.6.3 Perrigo Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Perrigo Gastrointestinal OTC Drugs Products Offered
12.6.5 Perrigo Recent Development
12.7 Abbott
12.7.1 Abbott Corporation Information
12.7.2 Abbott Description and Business Overview
12.7.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Abbott Gastrointestinal OTC Drugs Products Offered
12.7.5 Abbott Recent Development
12.8 Sanofi
12.8.1 Sanofi Corporation Information
12.8.2 Sanofi Description and Business Overview
12.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sanofi Gastrointestinal OTC Drugs Products Offered
12.8.5 Sanofi Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Corporation Information
12.9.2 Teva Pharmaceutical Description and Business Overview
12.9.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Products Offered
12.9.5 Teva Pharmaceutical Recent Development
12.10 Nestle
12.10.1 Nestle Corporation Information
12.10.2 Nestle Description and Business Overview
12.10.3 Nestle Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Nestle Gastrointestinal OTC Drugs Products Offered
12.10.5 Nestle Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Description and Business Overview
12.11.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered
12.11.5 GlaxoSmithKline Recent Development
12.12 Reckitt Benckiser
12.12.1 Reckitt Benckiser Corporation Information
12.12.2 Reckitt Benckiser Description and Business Overview
12.12.3 Reckitt Benckiser Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Reckitt Benckiser Products Offered
12.12.5 Reckitt Benckiser Recent Development
12.13 Purdue Pharma
12.13.1 Purdue Pharma Corporation Information
12.13.2 Purdue Pharma Description and Business Overview
12.13.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Purdue Pharma Products Offered
12.13.5 Purdue Pharma Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Gastrointestinal OTC Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastrointestinal OTC Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Gastrointestinal OTC Drugs Market Segments
Table 2. Ranking of Global Top Gastrointestinal OTC Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Laxatives
Table 5. Major Manufacturers of Anti-Flatulents
Table 6. Major Manufacturers of H2-Antaginists
Table 7. Major Manufacturers of Anti-Diarrheals
Table 8. Major Manufacturers of PPIs
Table 9. Major Manufacturers of Anti-Emetics
Table 10. Major Manufacturers of Other
Table 11. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Gastrointestinal OTC Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Gastrointestinal OTC Drugs Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Gastrointestinal OTC Drugs Sales Market Share by Regions (2015-2020)
Table 15. Global Gastrointestinal OTC Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Gastrointestinal OTC Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 17. Global Gastrointestinal OTC Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 18. Global Gastrointestinal OTC Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Global Gastrointestinal OTC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Gastrointestinal OTC Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal OTC Drugs as of 2019)
Table 21. Gastrointestinal OTC Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Gastrointestinal OTC Drugs Price (2015-2020) (USD/Pcs)
Table 24. Gastrointestinal OTC Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Gastrointestinal OTC Drugs Product Type
Table 26. Date of International Manufacturers Enter into Gastrointestinal OTC Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs)
Table 29. Global Gastrointestinal OTC Drugs Sales Share by Type (2015-2020)
Table 30. Global Gastrointestinal OTC Drugs Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Gastrointestinal OTC Drugs Revenue Share by Type (2015-2020)
Table 32. Gastrointestinal OTC Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 33. Global Gastrointestinal OTC Drugs Sales Share by Type (2021-2026)
Table 34. Global Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs)
Table 35. Global Gastrointestinal OTC Drugs Sales Share by Application (2015-2020)
Table 36. Global Gastrointestinal OTC Drugs Sales Share by Application (2021-2026)
Table 37. Global Gastrointestinal OTC Drugs Sales Market Share Forecast by Application (2021-2026)
Table 38. Global Gastrointestinal OTC Drugs Revenue by Application (2015-2020) (US$ Million)
Table 39. Global Gastrointestinal OTC Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 40. United States Gastrointestinal OTC Drugs Sales (K Pcs) of Key Companies (2015-2020)
Table 41. United States Gastrointestinal OTC Drugs Sales Share by Company (2015-2020)
Table 42. United States Gastrointestinal OTC Drugs Revenue (US$ Million) by Company (2015-2020)
Table 43. United States Gastrointestinal OTC Drugs Sales (K Pcs) by Type (2015-2020)
Table 44. United States Gastrointestinal OTC Drugs Sales Share by Type (2015-2020)
Table 45. United States Gastrointestinal OTC Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 46. United States Gastrointestinal OTC Drugs Price (K Pcs) by Type (2015-2020)
Table 47. United States Gastrointestinal OTC Drugs Sales (K Pcs) by Type (2021-2026)
Table 48. United States Gastrointestinal OTC Drugs Sales Share by Type (2021-2026)
Table 49. United States Gastrointestinal OTC Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 50. United States Gastrointestinal OTC Drugs Revenue Share by Type (2021-2026)
Table 51. United States Gastrointestinal OTC Drugs Price (K Pcs) by Type (2021-2026)
Table 52. United States Gastrointestinal OTC Drugs Sales (K Pcs) by Application (2015-2020)
Table 53. United States Gastrointestinal OTC Drugs Sales Share by Application (2015-2020)
Table 54. United States Gastrointestinal OTC Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 55. United States Gastrointestinal OTC Drugs Sales (K Pcs) by Application (2021-2026)
Table 56. United States Gastrointestinal OTC Drugs Sales Share by Application (2021-2026)
Table 57. United States Gastrointestinal OTC Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 58. United States Gastrointestinal OTC Drugs Revenue Share by Application (2021-2026)
Table 59. North America Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs)
Table 60. North America Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020)
Table 61. North America Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. North America Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020)
Table 63. Europe Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs)
Table 64. Europe Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020)
Table 65. Europe Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Europe Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020)
Table 67. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2015-2020) (K Pcs)
Table 68. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Region (2015-2020)
Table 69. Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2015-2020) (US$ Million)
Table 70. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Region (2015-2020)
Table 71. Latin America Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs)
Table 72. Latin America Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020)
Table 73. Latin Americaa Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million)
Table 74. Latin America Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020)
Table 75. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs)
Table 76. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020)
Table 77. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million)
Table 78. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020)
Table 79. GlaxoSmithKline Corporation Information
Table 80. GlaxoSmithKline Description and Business Overview
Table 81. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. GlaxoSmithKline Gastrointestinal OTC Drugs Product
Table 83. GlaxoSmithKline Recent Development
Table 84. Pfizer Corporation Information
Table 85. Pfizer Description and Business Overview
Table 86. Pfizer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Pfizer Product
Table 88. Pfizer Recent Development
Table 89. Johnson & Johnson Corporation Information
Table 90. Johnson & Johnson Description and Business Overview
Table 91. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Johnson & Johnson Product
Table 93. Johnson & Johnson Recent Development
Table 94. Bayer Corporation Information
Table 95. Bayer Description and Business Overview
Table 96. Bayer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Bayer Product
Table 98. Bayer Recent Development
Table 99. Procter & Gamble Corporation Information
Table 100. Procter & Gamble Description and Business Overview
Table 101. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Procter & Gamble Product
Table 103. Procter & Gamble Recent Development
Table 104. Perrigo Corporation Information
Table 105. Perrigo Description and Business Overview
Table 106. Perrigo Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Perrigo Product
Table 108. Perrigo Recent Development
Table 109. Abbott Corporation Information
Table 110. Abbott Description and Business Overview
Table 111. Abbott Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Abbott Product
Table 113. Abbott Recent Development
Table 114. Sanofi Corporation Information
Table 115. Sanofi Description and Business Overview
Table 116. Sanofi Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Sanofi Product
Table 118. Sanofi Recent Development
Table 119. Teva Pharmaceutical Corporation Information
Table 120. Teva Pharmaceutical Description and Business Overview
Table 121. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Teva Pharmaceutical Product
Table 123. Teva Pharmaceutical Recent Development
Table 124. Nestle Corporation Information
Table 125. Nestle Description and Business Overview
Table 126. Nestle Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. Nestle Product
Table 128. Nestle Recent Development
Table 129. Boehringer Ingelheim Corporation Information
Table 130. Boehringer Ingelheim Description and Business Overview
Table 131. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. Boehringer Ingelheim Product
Table 133. Boehringer Ingelheim Recent Development
Table 134. Reckitt Benckiser Corporation Information
Table 135. Reckitt Benckiser Description and Business Overview
Table 136. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 137. Reckitt Benckiser Product
Table 138. Reckitt Benckiser Recent Development
Table 139. Purdue Pharma Corporation Information
Table 140. Purdue Pharma Description and Business Overview
Table 141. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 142. Purdue Pharma Product
Table 143. Purdue Pharma Recent Development
Table 144. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 145. Key Challenges
Table 146. Market Risks
Table 147. Main Points Interviewed from Key Gastrointestinal OTC Drugs Players
Table 148. Gastrointestinal OTC Drugs Customers List
Table 149. Gastrointestinal OTC Drugs Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrointestinal OTC Drugs Product Picture
Figure 2. Global Gastrointestinal OTC Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Laxatives Product Picture
Figure 4. Anti-Flatulents Product Picture
Figure 5. H2-Antaginists Product Picture
Figure 6. Anti-Diarrheals Product Picture
Figure 7. PPIs Product Picture
Figure 8. Anti-Emetics Product Picture
Figure 9. Other Product Picture
Figure 10. Global Gastrointestinal OTC Drugs Sales Market Share by Application in 2020 & 2026
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Gastrointestinal OTC Drugs Report Years Considered
Figure 15. Global Gastrointestinal OTC Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global Gastrointestinal OTC Drugs Sales 2015-2026 (K Pcs)
Figure 17. Global Gastrointestinal OTC Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Gastrointestinal OTC Drugs Sales Market Share by Region in 2019
Figure 20. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Gastrointestinal OTC Drugs Revenue Market Share by Region in 2019
Figure 22. Global Gastrointestinal OTC Drugs Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Gastrointestinal OTC Drugs Revenue in 2019
Figure 24. Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020)
Figure 26. Global Gastrointestinal OTC Drugs Sales Market Share by Type in 2019
Figure 27. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2015-2020)
Figure 28. Global Gastrointestinal OTC Drugs Revenue Market Share by Type in 2019
Figure 29. Global Gastrointestinal OTC Drugs Market Share by Price Range (2015-2020)
Figure 30. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
Figure 31. Global Gastrointestinal OTC Drugs Sales Market Share by Application in 2019
Figure 32. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2015-2020)
Figure 33. Global Gastrointestinal OTC Drugs Revenue Market Share by Application in 2019
Figure 34. United States Gastrointestinal OTC Drugs Sales Growth Rate 2015-2026 (K Pcs)
Figure 35. United States Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. United States Gastrointestinal OTC Drugs Market Share in Global Market 2015-2026
Figure 37. United States 5 and 10 Largest Gastrointestinal OTC Drugs Players Market Share by Revenue in Gastrointestinal OTC Drugs in 2019
Figure 38. United States Gastrointestinal OTC Drugs Revenue Share by Type (2015-2020)
Figure 39. United States Gastrointestinal OTC Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 40. United States Gastrointestinal OTC Drugs Revenue Share by Application (2015-2020)
Figure 41. United States Gastrointestinal OTC Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. North America Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America Gastrointestinal OTC Drugs Sales Market Share by Country in 2019
Figure 45. North America Gastrointestinal OTC Drugs Revenue Market Share by Country in 2019
Figure 46. U.S. Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. U.S. Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Canada Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Canada Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Europe Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 51. Europe Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe Gastrointestinal OTC Drugs Sales Market Share by Country in 2019
Figure 53. Europe Gastrointestinal OTC Drugs Revenue Market Share by Country in 2019
Figure 54. Germany Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Germany Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. France Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. U.K. Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Asia Pacific Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 65. Asia Pacific Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Region in 2019
Figure 67. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Region in 2019
Figure 68. China Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. China Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Japan Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. South Korea Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. India Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Australia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Taiwan Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Indonesia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Thailand Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Malaysia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Malaysia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Philippines Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Philippines Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Vietnam Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Vietnam Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Latin America Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 91. Latin America Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Gastrointestinal OTC Drugs Sales Market Share by Country in 2019
Figure 93. Latin America Gastr
  • Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......
  • Global Lansoprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102
    The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......
  • Global Esomeprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89
    The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......
  • Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......
  • Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......
  • Global Lansoprazole Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136
    Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......
  • Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113
    Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs